| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |